Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The optimal treatment of hyperglycemia in general surgical patients with type 2 diabetes mellitus is not known. RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in patients with type 2 diabetes mellitus undergoing general surgery. Outcomes included differences in daily blood glucose (BG) and a composite of postoperative complications including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure. RESULTS: The mean daily glucose concentration after the 1st day of basal-bolus insulin and SSI was 145 ± 32 mg/dL and 172 ± 47 mg/dL, respectively (P < 0.01). Glucose readings <140 mg/dL were recorded in 55% of patients in basal-bolus and 31% in the SSI group (P < 0.001). There were reductions with basal-bolus as compared with SSI in the composite outcome [24.3 and 8.6%; odds ratio 3.39 (95% CI 1.50–7.65); P = 0.003]. Glucose <70 mg/dL was reported in 23.1% of patients in the basal-bolus group and 4.7% in the SSI group (P < 0.001), but there were no significant differences in the frequency of BG <40 mg/dL between groups (P = 0.057). CONCLUSIONS: Basal-bolus treatment with glargine once daily plus glulisine before meals improved glycemic control and reduced hospital complications compared with SSI in general surgery patients. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As discussed in Q12. How can glycemic targets be achieved in persons with T2D? as well as in the AACE Comprehensive Type 2 Diabetes Management Algorithm,73 some newer therapies carry a lower risk of hypoglycemia, which may enable more persons to safely achieve individualized target A1C levels.69,88–90”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized controlled trial has shown that basal plus bolus insulin plan improved glycemic outcomes and reduced hospital complications compared with a correction or supplemental insulin without basal insulin (formerly known as sliding scale) for people with type 2 diabetes admitted for general surgery (74).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In individuals undergoing noncardiac general surgery, basal insulin plus premeal short-or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with the reactive, correction-only short-or rapid-acting insulin coverage alone with no basal insulin dosing (74,145).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“…setting, observational and prospective clinical trials have shown that hyper-glycemia is associated with increased rates of hospital complications and mortality (8,10,11) and that improved glycemic control reduces multiorgan failure, systemic infections, and short-and long-term mortality (7,8).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 2×
“7 times increased rate of infection (13).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Cited by
Items 301–400 of 733
Silinskie, K., Kirshner, R. L., & Hite, M. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1q698 · Cited by 11
Management of hospitalized type 2 diabetes mellitus patients
Marín-Peñalver, J. J., Timon, I. M., & del Cañizo-Gómez, F. J. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0027 · Cited by 13
Simioni, N., Filippi, A., Scardapane, M., Nicolucci, A., Rossi, M. C., & Frison, V. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0271-6 · Cited by 13
“in favor of inpatient diabetes management programs involving effective and well-tolerated basal-bolus insulin regimens [1, 8, 9].”
BackgroundDonihi, A. C., Moorman, J. M., Abla, A., Hanania, R., Carneal, D., & MacMaster, H. W. (2018) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1041 · Cited by 12
“38 Finally, the Basal-Plus study demonstrated that medical and surgical patients with type 2 DM who were previously managed with diet, noninsulin agents, or low-dose insulin ( ≤ 0.4 units/kg/day) had similar improvements in glycemic control and hypoglycemia when treated with basal plus correction…”
MethodInfluentialKyi, M., Wang, J. N., & Fourlanos, S. (2020) · Diabetes Care · doi:10.2337/dc20-2469 · Cited by 11
Diretriz BRASPEN de Terapia Nutricional no Diabetes Mellitus
Campos, L. F., Borges, V. C., Barreto, P. A., González, M. C., Ceniccola, G. D., de Abreu, H. B., Alves, J. T. M., Segadilha, N. L. A. L., Kumbier, M. C. C., & Castro, M. G. (2020) · Braspen Journal · doi:10.37111/braspenj.diretrizdm2020 · Cited by 13
Dhatariya, K., & Umpierrez, G. E. (2022) · Diabetic Medicine · doi:10.1111/dme.14980 · Cited by 11
Self-citationValgardson, J. D., Merino, M., Redgrave, J., Hudson, J. I., & Hudson, M. (2015) · Endocrine Practice · doi:10.4158/ep14153.or · Cited by 11
Impact of a multifaceted strategy to improve perioperative diabetes care
Hommel, I., Wollersheim, H. C. H., Tack, C. J., Mulder, J., van Gurp, P. J. M., & Hulscher, M. (2016) · Diabetic Medicine · doi:10.1111/dme.13130 · Cited by 13
Strategies for intraoperative glucose management: a scoping review
Morin, N. P., Taylor, S., Krahn, D., Baghirzada, L., Chong, M., Harrison, T. G., Cameron, A., & Ruzycki, S. M. (2022) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-022-02359-1 · Cited by 11
Vellanki, P., Cardona, S., Galindo, R. J., Urrutia, M. A., Pasquel, F. J., Davis, G. M., Fayfman, M., Migdal, A., Peng, L., & Umpierrez, G. E. (2022) · Diabetes Care · doi:10.2337/dc21-1606 · Cited by 10
Self-citationAbdallah, S., Hammoud, S. M., Balushi, H. A., Loon, M. M., Salcedo, Y. E., Hassan, M. M. U., Cheema, M. J., Kadri, F., Shehryar, A., Rehman, A., et al. (2024) · Cureus · doi:10.7759/cureus.59849 · Cited by 13
“It advocates for healthcare institutions to prioritize developing and disseminating evidence-based guidelines tailored to individual patient factors, such as diabetes type, comorbidities, and surgical procedures [11].”
BackgroundMarino, E. C., Momesso, D., Toyoshima, M. T. K., de Almeida, M. F. O., Schaan, B. D., Negretto, L. A. F., Junior, A. C. S., Cukier, P., Genestreti, P., Feitosa, A. C. R., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01585-z · Cited by 10
Controle glicêmico no perioperatório: evidências para a prevenção de infecção de sítio cirúrgico
Freitas, P. S., Romanzini, A. E., Ribeiro, J. C., Bellusse, G. C., & Galvão, C. M. (2013) · Revista Eletrônica de Enfermagem · doi:10.5216/ree.v15i2.23898 · Cited by 10
“Já no segundo estudo, os resultados evidenciaram que a administração de insulina glargina e glulisina manteve de forma mais efetiva o controle glicêmico, reduzindo as complicações no PO como ISC, pneumonia e bacteremia((19)).”
BackgroundInfluentialPremixed Insulin Analogue Compared with Basal-Plus Regimen for Inpatient Glycemic Control
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., Madrigal‐Santillán, E., Morales‐González, J. A., Madrigal‐Bujaidar, E., & Aguilar-Faisal, L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0176 · Cited by 13
“15,21,22,25,37 FIG.”
Helmle, K. E., Dechant, A., & Edwards, A. L. (2018) · Clinical Diabetes · doi:10.2337/cd17-0078 · Cited by 10
Glycemic Management in the Bariatric Surgery Population: A Review of the Literature
Howard, M. L., Steuber, T. D., & Nisly, S. A. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2120 · Cited by 10
Management of Hyperglycemia in Hospitalized Patients
Gianchandani, R. Y., Wei, M., & Demidowich, A. P. (2024) · Annals of Internal Medicine · doi:10.7326/annals-24-02754 · Cited by 12
Gómez‐Huelgas, R., Lopez-Carmona, M. D., Jansen‐Chaparro, S., Sobrino, B., Chaves, M., Martin-Gallardo, P., Garcia-Fernandez, C., & Bernal-López, M. R. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0520-8 · Cited by 13
“Both the protocol scheme and the insulin dosage used were based on the results of the main consensus existent in the literature [6, 8, 9] and the only randomized study that compares traditional fast-acting insulin on demand with basal bolus therapy in the inpatient management of patients with hyperglycemia [5, 11].”
BackgroundMethodWagstaff, A. E., & Cheung, N. W. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0444-2 · Cited by 11
Allende-Vigo, M. Z., González-Rosario, R. A., González, L., Sánchez, V. M., Vega, M., Alvarado, M., & Ramón, R. O. (2013) · Endocrine Practice · doi:10.4158/ep13199.or · Cited by 13
Ramos, A., Zapata, L., Vera, P., Betbese, A. J., & Pérez, A. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.08.005 · Cited by 11
“Use of basal-prandial-correction therapy with insulin analogs constitutes a suitable regimen for inpatient management of hyperglycemia.(10,18) Patients receiving continue EN or TPN require basal insulin therapy plus a correction dose every 4--6 h, but they do not need prandial doses since nutrients are delivered conti…”
BackgroundPerez-Belmonte, L. M., Ricci, M., Sanz‐Cánovas, J., Millán‐Gómez, M., Osuna‐Sánchez, J., Ruiz-Moreno, M. I., Bernal-López, M. R., Lopez-Carmona, M. D., Jiménez-Navarro, M. F., Gómez‐Doblas, J. J., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163540 · Cited by 12
“In non-critically ill patients with T2D, a multidose insulin regimen that involves once-daily basal insulin and bolus of rapid-acting insulin before meals [10,11] and, most recently, the use of dipeptidyl peptidase-4 (DPP-4) inhibitors alone or in combination with basal insulin [12–19] are the preferred therapies for…”
BackgroundPerera, N., Harding, A., Constantino, M., Molyneaux, L. M., McGill, M. J., Chua, E., Twigg, S., Ross, G., & Yue, D. (2011) · Practical Diabetes · doi:10.1002/pdi.1612 · Cited by 11
Why Won't the Sliding Scale Go Away?
Miller, D. B. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)54010-9 · Cited by 10
How to manage type 2 diabetes in medical and surgical patients in the hospital
Umpierrez, G. E. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78gr.11001 · Cited by 10
Self-citationInpatient Use of Computer-Guided Insulin Devices Moving into the Non–Intensive Care Unit Setting
Gianchandani, R. Y., & Umpierrez, G. E. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0213 · Cited by 10
“5 units/kg/day, depending on the renal function of patients.(2,3,13) Normal basal bolus ratios are approximately 50% basal and 50% bolus, with bolus doses further divided somewhat equally among three meals.”
BackgroundInfluentialSelf-citationPichardo-Lowden, A. R., & Haidet, P. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818817005 · Cited by 10
Inpatient hyperglycemia and transitions of care: A systematic review
Lansang, M. C., Zhou, K., & Korytkowski, M. T. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.016 · Cited by 9
Insight Into the Perioperative Management of Type 2 Diabetes
Zaidi, S. O., Khan, Y., Razak, B. S., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.6878 · Cited by 9
“Perioperative insulin-based management in the form of basal-bolus is quite effective in attaining blood glucose targets than intermittent bolus with rapid-acting insulin in type 2 diabetes [43].”
BackgroundRushakoff, R. J., Sullivan, M. M., Seley, J. J., Sadhu, A., O’Malley, C. W., Manchester, C. S., Peterson, E. D., & Rogers, K. M. (2014) · Healthcare · doi:10.1016/j.hjdsi.2014.06.004 · Cited by 9
Schwartz, S. S., & DeFronzo, R. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0466-9 · Cited by 9
Inpatient management of type 2 Diabetes Mellitus: Does choice of insulin regimen really matter?
Akhtar, S. T., Mahmood, K., Naqvi, I. H., & Vaswani, A. S. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.304.4920 · Cited by 9
Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era
Aljehani, F., Funke, K., & Hermayer, K. L. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.07.005 · Cited by 11
Ruzycki, S. M., Harrison, T. G., Enns, E., McKeen, J. A., Helmle, K. E., & Cameron, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002445 · Cited by 10
Toyoshima, M. T. K., Brandes, P. H. R., Lauterbach, G. D. P., Moraes, J. R. A., de Paiva, E. F., Umpierrez, G. E., Nery, M., & Kondo, R. H. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000496 · Cited by 9
“These results are similar to that of prospective randomized studies evaluating glycemic control and insulin therapy regimens, such as RABBIT2 (22), DEAN (23) and Basal Plus (5) studies.”
ResultSelf-citationDemidowich, A. P., Stanback, C., & Zilbermint, M. F. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15190 · Cited by 13
Said, E., Farid, S. F., Sabry, N. A., & Fawzi, M. (2013) · Pharmacology & Pharmacy · doi:10.4236/pp.2013.47080 · Cited by 9
Diabetesmanagement im Krankenhaus (Update 2019)
Mader, J. K., Aberer, F., Brix, J. M., Föger, B., Hochfellner, D. A., Kietaibl, A.-T., Ludvik, B., Resl, M., Ress-Winkel, C., Stechemesser, L., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1447-z · Cited by 11
Dungan, K. M., Osei, K., Sagrilla, C., & Binkley, P. F. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12069 · Cited by 9
“Among patients receiving SQ insulin, basal and prandial insulin were administered in approximately equal total daily doses with correction dosing and adjustments based on a published algorithm [21].”
MethodGangopadhyay, K. K., Bantwal, G., Talwalkar, P., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 11
Perioperative Glycemic Control During Colorectal Surgery
Thompson, R. E., Broussard, E. K., Flum, D. R., & Wisse, B. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0722-x · Cited by 10
Glycemic Management in the Inpatient Setting
Schmeltz, L. R., & Ferrise, C. (2012) · Hospital Practice · doi:10.3810/hp.2012.04.969 · Cited by 11
“be a safe and effective dosing estimate.(72,73) In patients with renal dysfunction (creatinine level .”
BackgroundRabizadeh, S., Tavakoli Ardakani, M. A., Mouodi, M., Bitaraf, M., Shab-Bidar, S., Esteghamati, A., & Nakhjavani, M. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01434-7 · Cited by 8
Hypoglycemia Rates After Restriction of High-Dose Glargine in Hospitalized Patients
Lee, S. Y., Askin, G., McDonnell, M. E., Arnold, L. M., & Alexanian, S. M. (2016) · Endocrine Practice · doi:10.4158/ep161288.or · Cited by 8
Management of Inpatient Hyperglycemia and Diabetes in Older Adults
Davis, G. M., DeCarlo, K., Wallia, A., Umpierrez, G. E., & Pasquel, F. J. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.008 · Cited by 8
Self-citationRuzycki, S. M., Kuzma, T., Harrison, T. G., McKeen, J. A., Helmle, K. E., Beesoon, S., Brindle, M. E., & Cameron, A. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.11.007 · Cited by 8
Development of insulin and its pharmacology and perioperative use: a narrative review
Dhatariya, K., Levy, N., Stubbs, D. J., Frank, C., Tinsley, S. L., & Knaggs, R. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.05.006 · Cited by 8
“43 Consequently, ‘sliding scale ’ insulin for perioperative glycaemic control is increasingly discouraged.”
InfluentialEffectively Identifying the Inpatient With Hyperglycemia to Increase Patient Care and Lower Costs
Mabrey, M., McFarland, R., Young, S. L., Cooper, P. L., Chidester, P., & Rhinehart, A. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.04.1098 · Cited by 8
Selecting Insulin Regimens for the Management of Non-ICU Patients With Type 2 Diabetes
Migdal, A. L., Idrees, T., & Umpierrez, G. E. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab134 · Cited by 8
“Several randomized controlled studies and metaanalyses have reported better glucose control and reduced risk of hospital-acquired infections with basal-bolus regimen but no difference in mortality or length of hospital stay compared to sliding scale [3,4].”
BackgroundSelf-citationDungan, K. M., Graessle, K., & Sagrilla, C. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0094 · Cited by 9
Polderman, J. A. W., Houweling, P. L., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2014) · BMC Anesthesiology · doi:10.1186/1471-2253-14-91 · Cited by 10
“This is also in concordance with the population studied in the RABBIT 2 surgery trial [19], showing a reduction in postoperative complications when lowering glucose by 1 mmol l.”
MethodResultPerioperative Management of the Diabetic Patient
Soldevila, B., Lucas, A., Zavala, R., & Mauricio, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-28821-5_8 · Cited by 8
Patient Care Interventions to Reduce the Risk of Surgical Site Infections
Love, K. L. (2016) · AORN Journal · doi:10.1016/j.aorn.2016.10.002 · Cited by 9
Reactive Rather than Proactive Diabetes Management in the Perioperative Period
Hommel, I., van Gurp, P. J. M., den Broeder, A. A., Wollersheim, H. C. H., Atsma, F., Hulscher, M., & Tack, C. J. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-105501 · Cited by 8
“Timely evaluation and adequate management of diabetes in the pre- and perioperative period has been found to improve perioperative glucose control [23, 24].”
BackgroundBrand, D. A., Peragallo‐Dittko, V., Fazzari, M. J., Islam, S., Jacobson, A. M., & Radin, M. S. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0498 · Cited by 8
Perioperative Glycemic Management for Patients with and without Diabetes: A Review for Internists
Ruzycki, S. M., Harrison, T. G., Cameron, A., Helmle, K. E., & McKeen, J. A. (2021) · Canadian Journal of General Internal Medicine · doi:10.22374/cjgim.v16i1.435 · Cited by 9
Lin, S.-D., Tu, S., Lin, M., Jhang, Y.-L., & Hsieh, M. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1080113 · Cited by 8
“In two recent randomized, controlled trials, a significantly higher percentage of glucose values within target range was achieved by the BBI regimen than by the SSI regimen [13,14].”
MethodDungan, K. M., Osei, K., Gaillard, T. R., Moore, J., & Binkley, P. F. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2569 · Cited by 8
“doses with correction dosing and adjustments based upon a published algorithm [16].”
MethodManagement of diabetes by a healthcare team in a cardiology unit: a randomized controlled trial
Moraes, M. A., Rodrigues, J. A., Cremonesi, M., Polanczyk, C. A., & Schaan, B. D. (2013) · Clinics · doi:10.6061/clinics/2013(11)03 · Cited by 11
“Basal-bolus treatment with dose correction using longacting, once-daily insulin and short-acting insulin prior to meals in patients with type 2 diabetes was previously shown to improve glycemic control and to reduce hospital complications compared with SSI use in clinical (14) and general surgery (7) patients.”
BackgroundMethodThe potential role of incretin therapy in the hospital setting
Macdonald, J. J., Neupane, S., & Gianchandani, R. Y. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0005-5 · Cited by 8
“Tight glucose targets may be beneficial in select patient populations such as post-operative, steroid-induced, or trauma-related hyperglycemia [6, 7], but this is limited by hypoglycemia, which is also a known predictor of poor outcomes [7, 8].”
BackgroundGlucometrics and Insulinometrics
Thompson, B., & Cook, C. B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0964-2 · Cited by 8
Khoury, G. E., Mansour, H., Kabbara, W. K., Chamoun, N. R., Atallah, N., & Salameh, P. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180119142254 · Cited by 9
Guidelines for Care of the Hospitalized Patient with Hyperglycemia and Diabetes
Crawford, K. (2012) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2012.11.001 · Cited by 12
Coudenys, E., De Waele, E., Meers, G., Collier, H., & Pen, J. J. (2018) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2017.12.001 · Cited by 7
Barmanray, R., Kyi, M., Colman, P. G., & Fourlanos, S. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221140126 · Cited by 7
“6,24 It is thus consistent that this linked glycemic treatment phenomenon is similarly manifest when considering groups of individuals at the scale of a hospital.”
BackgroundZhao, C., Shi, J., Zhu, N., Yang, P., Xiang, B., Dai, Y., & Wang, S. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103140 · Cited by 10
Bajwa, S. J., Baruah, M., Kalra, S., & Kapoor, M. (2015) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/0970-9185.155141 · Cited by 7
“However, incidence of hypoglycemia was higher in patients treated with basal-bolus regimen as compared to SSI.”
BackgroundInfluentialHealth Information Technology and Hospital Patient Safety: A Conceptual Model to Guide Research
Paez, K., Roper, R., & Andrews, R. M. (2013) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(13)39055-2 · Cited by 7
Diabetes and orthopaedic surgery: a review
Kumar, V., Patel, B. Y., & Robinson, A. H. N. (2019) · Orthopaedics and Trauma · doi:10.1016/j.mporth.2019.05.002 · Cited by 8
Caimari, F., González, C., Ramos, A., Chico, A. I., Cubero, J. M., & Pérez, A. (2016) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2016.08.001 · Cited by 7
Pearson, K. K., Reiland, S. A., Meara, J. G. O., Brown, J. K., Fedraw, L. A., & Mapes, D. L. (2016) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000004 · Cited by 7
“…to sliding scale insulin regimens on the basis of improved glycemic control, decreased length of stay (McKnight and Carter, 2008; Murphy et al., 2009; Nau et al., 2010; Schnipper et al., 2009; Umpierrez et al., 2007), and low rates of hypoglycemia (Schnipper et al., 2009; Umpierrez et al., 2007).”
BackgroundCardiovascular Safety of Antidiabetic Drugs in the Hospital Setting
Seggelke, S. A., Lindsay, M. C., Hazlett, I., Sanagorski, R., Eckel, R. H., & Wang, C. C. L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0884-1 · Cited by 7
Ramos, A., Rabasa, F., Mendoza, L. C., Cardenete, J., Gill, P., Morilla, A., Cardona, D., & Pérez, A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0433-1 · Cited by 7
“In surgical patients, hyperglycemia increases risks of perioperative complications, length of stay and mortality [10, 11].”
BackgroundD’Souza, S., & Kruger, D. F. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00920-z · Cited by 7
Gupta, T., & Hudson, M. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1055 · Cited by 7
Manejo de pacientes diabéticos hospitalizados
Román-Gonzaléz, A., Cardona, A., Gutiérrez-Restrepo, J., & Palacio, A. (2018) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v66n3.61890 · Cited by 15
A survey: perioperative diabetes medications and glucose control—time to re-examine management?
Brown, R., Siddiqui, U., & Paul, J. (2019) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-019-01311-0 · Cited by 7
Glycemic Targets in Hospital and Barriers to Attaining Them
Miller, D. B. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.001 · Cited by 7
Retrospective review of postoperative glycemic control in patients after distal pancreatectomy
Liu, A., Carmichael, K. A., Schallom, M. E., & Klinkenberg, W. D. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.03.060 · Cited by 7
Insulin before surgery (November 2013)
Ditch, K., & Moore, J. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81c.06001 · Cited by 7
Fayfman, M., Hochberg, I., Magee, M. F., RASHIED, A. A., Chaudhry, N. A., Jagannathan, R., Pasquel, F. J., & Umpierrez, G. E. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.06.014 · Cited by 6
Self-citationHAW, J. S., Farrokhi, F., Smiley, D. D., Peng, L., Reyes, D., Newton, C. A., Pasquel, F. J., Vellanki, P., & Umpierrez, G. E. (2015) · Endocrine Practice · doi:10.4158/ep14540.or · Cited by 6
Self-citationManaging diabetes mellitus in the surgical patient
Coan, K. E., Apsey, H. A., Schlinkert, R. T., Stearns, J. D., & Cook, C. B. (2014) · Diabetes Management · doi:10.2217/dmt.14.42 · Cited by 6
Sáenz-Abad, D., Gimeno-Orna, J. A., Sierra-Bergua, B., Lahoza-Pérez, M. C., & Pérez‐Calvo, J. I. (2015) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272015000300004 · Cited by 7
Closer to closing the loop on inpatient glycaemia
Rayman, G. A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30327-8 · Cited by 7
Evaluation of the Safety and Efficacy of Metformin Use in Hospitalized, Non–Critically Ill Patients
Alauddin, T., & Petite, S. E. (2020) · Journal of Pharmacy Technology · doi:10.1177/8755122520911689 · Cited by 6
“5) Length of stay (days) 4 (3-7) Inpatient metformin duration (days) 3 (2-5) Inpatient non-insulin use SU 48 (24) DPP-IV 24 (12)”
BackgroundUpdates on the Management of Hyperglycemia in Hospitalized Adult Patients
Razavi, L., & Omoregie, C. (2023) · Endocrines · doi:10.3390/endocrines4030037 · Cited by 7
“Additionally, the rate of complications such as wound infection, pneumonia, acute kidney injury, and acute respiratory failure was reduced in the basal/bolus insulin regimen group vs. the sliding-scale group (8.6% and 24.3%; odds ratio 3.39 (95% confidence interval [CI]: 1.50–7.65); p = 0.003) [57].”
BackgroundMethodInfluentialMontenegro, A. M. R., Áñez, R., Pastor, A. G.-S., & Albarrán, O. G. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.02.007 · Cited by 6
Non-ICU Hospital Care of Diabetes Mellitus in the Elderly Population
Gilden, J. L., & Gupta, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0596-3 · Cited by 7
Management of hyperglycemia in the neurosurgery patient
Daniel, R., Villuri, S., & Furlong, K. (2017) · Hospital Practice · doi:10.1080/21548331.2017.1370968 · Cited by 8
“glargine) and bolus insulin (meal and correction dose) yields significantly better outcomes that management with the correction doses only, or management with premixed insulin [27,39].”
BackgroundMethodEvidence-based therapeutics for hyperglycemia in hospitalized noncritically ill patients
Gracia‐Ramos, A. E., Carretero‐Gómez, J., Mendez, C. E., & Carrasco-Sánchez, F. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1997288 · Cited by 7
Rosinha, P. M. O., Inácio, I. M. R., Teixeira, S., Amaral, C., & Cardoso, H. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000452 · Cited by 6
“Therefore, the basal-bolus regimen is, according to these recommendations, the preferred treatment for non-critically ill hospitalized patients as long as they have good nutritional intake (4-10).”
MethodHussein, M. H., Toraih, E. A., Reisner, A. S. C., Shihabi, A., Al‐Quaryshi, Z., Borchardt, J. A., & Kandil, E. H. (2022) · Gland Surgery · doi:10.21037/gs-21-648 · Cited by 6
“Patients with diabetes are more likely to require surgery in their lifetimes than non-diabetic patients (3,4).”
Bariatric versus diabetes surgery after five years of follow up
Lee, W., Almulaifi, A. M., Chong, K., Yao, W.-C., Tsou, J. J., Ser, K., Lee, Y.-C., Chen, S., & Chen, J. (2015) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2015.04.001 · Cited by 7
“The reason for the more severe complication in the DS patients might be related to the compromised cardiovascular system and depressed immunity in patients with poorly controlled diabetes.(32,33) In this study, the patient characteristics are significantly different.”
BackgroundInpatient Glycemic Protocol for Patients with Diabetes Undergoing Bariatric Surgery
Machnica, K., Pannain, S., Schulwolf, E., Bartfield, J. K., & Emanuele, M. A. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1860-y · Cited by 6
Thabit, H., Kumareswaran, K., Haidar, A., Leelarathna, L., Caldwell, K., Elleri, D., Allen, J. M., Nodale, M., Wilinska, M. E., Jackson, N. C., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4519 · Cited by 7
Masse, J., Giuliano, C. A., Brown, S. A., & Paxton, R. A. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616677030 · Cited by 6
Caimari, F., González, C., Ramos, A., Chico, A. I., Cubero, J. M., & Pérez, A. (2015) · Cirugía Española · doi:10.1016/j.ciresp.2015.02.007 · Cited by 8
Transitioning from intravenous to subcutaneous insulin in the medical intensive care unit
Zhou, K., Williams, M. F., Esquivel, M. A., Song, A., Rahman, F., Bena, J., Lam, S. W., Rathz, D. A., & Lansang, M. C. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.016 · Cited by 6
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Department of Medicine, Emory University, Atlanta, Georgia
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 256-261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024330
- OpenAlex
- W2106327047
- Cited by
- 720
- References
- 24
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 37 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 54 · 2016: 48 · 2015: 51 · 2014: 61 · 2013: 53 · 2012: 44
- FWCI
- 48.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, K12RR017643, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, general surgery, perioperative hyperglycemia, glycemic control, postoperative complications, wound infection, respiratory failure, acute kidney injury, bacteremia
- MeSH terms
- Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Postoperative Complications, Prospective Studies, General Surgery, Perioperative Care, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.